|
Volumn 23, Issue 2 SUPPL., 2011, Pages 76-77
|
Total hip arthroplasty and bone fragility
|
Author keywords
Osteoporosis; Stem fixation; Total hip arthroplasty
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
BONE CEMENT;
PARATHYROID HORMONE[1-34];
STRONTIUM RANELATE;
BONE FRAGILITY;
BONE MASS;
BONE REMODELING;
BONE TISSUE;
CANCELLOUS BONE;
CONFERENCE PAPER;
CORTICAL BONE;
DENMARK;
DISEASE COURSE;
DRUG BLOOD LEVEL;
EUROPE;
FRACTURE FIXATION;
HIP FRACTURE;
HUMAN;
IMPLANT;
OSTEOARTHRITIS;
OSTEOLYSIS;
OSTEOPOROSIS;
PREOPERATIVE PERIOD;
RISK ASSESSMENT;
SURGEON;
SURGICAL TECHNIQUE;
SWEDEN;
TENSILE STRENGTH;
TOTAL HIP PROSTHESIS;
TREATMENT PLANNING;
UNITED STATES;
AGED;
AGING;
ARTHROPLASTY, REPLACEMENT, HIP;
BONE AND BONES;
BONE REMODELING;
BONE SUBSTITUTES;
CEMENTATION;
DIPHOSPHONATES;
HIP PROSTHESIS;
HUMANS;
OSSEOINTEGRATION;
OSTEOPOROSIS;
OSTEOPOROTIC FRACTURES;
PROSTHESIS FAILURE;
|
EID: 80053029199
PISSN: 15940667
EISSN: 17208319
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (14)
|
References (6)
|